Dare Bioscience, Inc. — Director's Dealing 2025

Jan 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2025-01-28

Reporting Person: Haring-Layton MarDee (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-28	Employee Stock Option (right to buy)	$3.27	A	38000	Acquired	2035-01-28	Common stock (38000)	Direct

Footnotes

F1: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.